Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NovaCardia
company
About
NovaCardia Inc. develops drugs related to the treatment of cardiovascular diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Close
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing a portfolio of novel small molecule drugs. NovaCardia will be focused initially on the acute cardiac care marketplace.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$88M
NovaCardia has raised a total of
$88M
in funding over 2 rounds. Their latest funding was raised on
Apr 6, 2007 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2007 | Series B | $18M | 1 | — | — | Detail |
| Sep 24, 2006 | Series B | $48M | 1 | — | — | Detail |
| Apr 22, 2005 | Series A | — | 1 | — | — | Detail |
| Sep 4, 2003 | Series Unknown | $22M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
NovaCardia is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
